This inventor holds 1 USPTO granted patent. Top assignees: Children's Medical Center Corporation, Hybridon, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,076 
1 out of 98 
Years Active: 1998
Title: Lois Elaine Hodgson Smith: Innovator in Neovascularization Treatment
Introduction
Lois Elaine Hodgson Smith is a notable inventor based in West Newton, MA (US). She has made significant contributions to the field of medical science, particularly in the area of neovascularization. Her innovative work has the potential to impact various disorders associated with this condition.
Latest Patents
Lois holds a patent titled "Inhibition of neovascularization using VEGF-specific oligonucleotides." This patent discloses methods for reducing neovascularization and treating disorders linked to it. The methods involve administering a synthetic oligonucleotide specific for vascular endothelial growth factor (VEGF) nucleic acid, which effectively inhibits the expression of VEGF.
Career Highlights
Throughout her career, Lois has worked with prominent organizations, including Hybridon, Inc. and Children's Medical Center Corporation. Her experience in these institutions has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Lois has collaborated with various professionals, including her coworker Gregory S. Robinson. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Lois Elaine Hodgson Smith is a pioneering inventor whose work in neovascularization treatment showcases her dedication to improving medical science. Her contributions continue to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile